TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ISPR

Ispire Technology Inc.

Consumer Defensive · Tobacco · listed since 2023

1.30$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Ispire Technology Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 1.10 $ to 3.70 $ · Last price: 1.30 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.1$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 57m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 34.4%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 2.1

Performance

Perf. 1M ?Price performance over the last month. -32.40%
Perf. 3M ?Price performance over the last 3 months. -33.50%
Perf. 6M ?Price performance over the last 6 months. -53.50%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -30.00%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -58.1%
Perf. 1Y ?Price performance over the last 12 months. -58.99%
Perf. 3Y ?Price performance over the last 3 years. -85.73%
Perf. 5Y ?Price performance over the last 5 years. -75.89%
Perf. Since Inception ?Price performance since the first available trading day (04/04/2023) — with a complete history, that is since the IPO. -82.78%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 1.50$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 1.60$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 2.00$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 37.5
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 69.4%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 110.9%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. –
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 0.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. –
P/B ?Price-to-book ratio: market value relative to book equity. –
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 0.8
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. -41.9
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. –

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 14.6%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. –
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. -38.2%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -428.6%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -22.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. –
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. –
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. warning zone -0.72
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 6 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). -28.70%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -16.07%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 19.03%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 91.70%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 4
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 21
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 42
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. D (40 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Tobacco

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Ispire Technology Inc. ISPR 0.1 – -41.9 14.6 – -16.1 -59.0
Philip Morris International Inc PM 287.7 27.6 18.2 67.5 36.0 7.3 18.7
Altria Group MO 113.0 15.0 11.6 87.0 62.3 -1.5 13.6
RLX Technology Inc RLX 2.1 15.3 10.5 34.9 16.7 43.9 -29.5
Turning Point Brands Inc TPB 1.3 – 14.2 56.7 – 28.4 -32.5
Air Global PLC AIIR 1.3 24.5 14.8 – 0.0 6.1 –
Universal Corporation UVV 1.1 35.7 11.0 17.4 3.7 -0.8 -16.2
Median of companies shown 1.3 24.5 11.6 45.8 16.7 6.1 -22.8

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2021 · Revenue: 63 $M 2021 · Operating income: 4 $M 2021 · Net income: 3 $M 2022 · Revenue: 88 $M 2022 · Operating income: -1 $M 2022 · Net income: -2 $M 2023 · Revenue: 116 $M 2023 · Operating income: -4 $M 2023 · Net income: -6 $M 2024 · Revenue: 152 $M 2024 · Operating income: -14 $M 2024 · Net income: -15 $M 2025 · Revenue: 127 $M 2025 · Operating income: -38 $M 2025 · Net income: -39 $M
20212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2021 63 4 3 0.06 5 14 94
2022 88 -1 -2 -0.04 -8 12 101
2023 116 -4 -6 -0.11 -8 31 90
2024 152 -14 -15 -0.27 -18 34 123
2025 127 -38 -39 -0.69 -7 1 102

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 41.8 $M Q4 2025: Q1 · 26.2 $M Q1 2025: Q2 · 20.1 $M Q2 2025: Q3 · 30.4 $M Q3 2025: Q4 · 20.3 $M Q4 2026: Q1 · 18.7 $M Q1 2026: Q2 · 26.7 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.14 – 42 0.30 -19.10 -3 -3
2025: Q1 -0.19 – 26 -12.70 -41.40 -13 -12
2025: Q2 -0.26 – 20 -46.10 -73.40 5 4
2025: Q3 -0.06 – 30 -22.80 -10.70 -13 -12
2025: Q4 -0.12 – 20 -51.50 -32.50 -4 -4
2026: Q1 -0.17 – 19 -28.70 -51.00 2 2
2026: Q2 -0.24 7.70 27 32.80 -51.70 3 3

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 2 of our scanner strategies — each hit links to the scanner.

Breakout & Setup

Momentum & Trend

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 1
Price Target (average) 5.00$
Distance to price 284.6% The price target sits 284.6% above the current price.

Distribution of Recommendations

Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
06/30/2027 0.09 -0.03 – 0.21 98 115.5% 2
06/30/2028 0.24 0.24 – 0.24 85 166.7% 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.

How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

5 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years 13.1%
  • More than 10% revenue growth is expected for the coming year 19.0%
  • Share count grows by less than 3% a year 2.6%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -22.7%
  • Gross margin at 40% or higher and without meaningful erosion 17.8%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 17 m net cash
  • Operating cash flow covers the profits of the last three years 27 m
  • Return on capital at 15% or higher, or up versus two years ago -127.5%
  • Insiders hold at least 10% or are net buyers 66.7%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

2/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 19.1%
  • Exp. sales growth 3Y > 5% -18.4%
  • EBIT growth 10Y > 5% –
  • Exp. EBIT growth 3Y > 5% -18.4%
  • Net debt < 4x EBIT –
  • EBIT positive, 10Y straight 1
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% –
  • ROCE > 15% -127.5%
  • Expected return > 10% -27.9%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Burch Christopher Robert Director Other 45,760 0.00 –
Aug 14, 2026 Cox Brent Director Other 53,555 0.00 –
Aug 14, 2026 Fargis John Director Other 45,760 0.00 –

View all insider transactions →

The company

About the Company

Ispire Technology Inc. erforscht, entwickelt, entwirft, vermarktet, verkauft und vertreibt weltweit E-Zigaretten und Cannabis-Vaping-Produkte unter den Marken Ispire und Aspire.

Employees
81
Headquarters
Los Angeles, CA
Address
19700 Magellan Drive, 90502 Los Angeles, United States
Phone
310 742 9975
IPO Date
04/04/2023
ISIN
US46501C1009

Management

Management
Name Title Birth Year
Tuanfang Liu Chairman & CEO 1973
Steven P. Przybyla President, Chief Legal Officer & Secretary 1987
Jie Yu Chief Financial Officer 1986
Michael Wang Chief Executive Officer of Aspire North America –
Lauren Stower Chief Impact Officer 1985
Dennis Lider Senior Vice President of Cannabis Product Sales –
John Patterson Senior Vice President of International Nicotine –

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/17/2026 Ispire Technology Inc. (ISPR): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 08/17/2026 Ispire Technology Inc. (ISPR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 07/17/2026 Ispire Technology Inc. (ISPR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?